L-Carnitine Injections for Weight Loss: What the Evidence Shows

L-carnitine injections have not been shown to cause weight loss. The case for them is borrowed from oral supplement trials, where pooled results show about 1.2 kg more loss than placebo over several weeks to months.^[5] Injected carnitine has been tested for weight in one seven-day study during a fast.^[8] The only FDA-approved carnitine injection, levocarnitine (Carnitor), is labeled for carnitine deficiency in inherited metabolic disorders and dialysis, and for intravenous use only.^[1] Adding L-carnitine to a compounded GLP-1 vial has never been tested. FDA says the safety and effectiveness of mixing semaglutide with other ingredients “has not been established.”^[2]

What L-carnitine is, and why the body rarely runs short

L-carnitine is a small molecule that ferries long-chain fatty acids into mitochondria, where they are burned for energy.^[1] That is the whole sales pitch: more carnitine, more fat burned. The body makes its own from amino acids, and meat and dairy supply more. Vegans and meat eaters in one Cleveland Clinic study had similar fasting blood carnitine levels.^[13]

Real deficiency happens in specific situations. The levocarnitine label names inherited disorders of fat and organic-acid metabolism, and people with kidney failure on hemodialysis, who lose carnitine in the dialysis fluid and make less of it.^[1] Those are the people the drug is approved for. A healthy adult who wants to lose weight is not on that list.

The one approved L-carnitine injection

Levocarnitine is the drug name for L-carnitine. The brand injection, Carnitor, comes as 1 gram in a 5 mL vial, and its label is plain about what it is for:

“For the acute and chronic treatment of patients with an inborn error of metabolism which results in secondary carnitine deficiency. For the prevention and treatment of carnitine deficiency in patients with end stage renal disease who are undergoing dialysis.”^[1]

— CARNITOR (levocarnitine) Injection prescribing information, DailyMed

Two lines on the label matter for anyone paying for a shot. After an intravenous dose, about 76% of the carnitine leaves in the urine within 24 hours.^[1] And even in dialysis patients, who are genuinely low, the label says the effect of supplemental carnitine on symptoms and clinical outcomes “have not been determined.”^[1] If that is the state of the evidence in people who need it, the case for people who do not is thinner still.

Because levocarnitine is the active ingredient in an approved drug, a pharmacy compounding under section 503A may use it as a bulk ingredient.^[3] That is a legal route to make the product. It says nothing about whether the product works for weight.

The oral evidence: a small, real, fading effect

Nearly all the weight data for carnitine come from capsules and drinks, not shots. Four pooled analyses of randomized trials point the same way:

Read the size first. About 1.1 to 1.3 kg, or 2.5 to 3 pounds, beyond whatever diet or placebo produced. The 2016 analysis found the gap narrowed over time, which is the opposite of what a fat-burning agent should do.^[4] Two of the analyses found no change in body fat percentage or waist size.^[5][6] The trials were mostly small and short, and the umbrella review found the results varied far more than chance would explain.^[7]

For scale: in the STEP 1 trial, adults on weekly semaglutide 2.4 mg lost 14.9% of their body weight over 68 weeks, against 2.4% on placebo.^[18] For a 100 kg person that difference is more than 12 kg. Oral carnitine’s pooled effect is roughly a tenth of that, on a much shorter timeline and with much weaker trials behind it. Our review of supplements marketed as natural GLP-1s applies the same yardstick to that shelf.

What injected carnitine has actually been tested for

The injection pitch rests on one idea: swallowed carnitine is poorly absorbed, so injecting it must work better. The first half is true. The label puts the absolute bioavailability of oral levocarnitine at about 15%.^[1] The second half does not follow, because the bottleneck is not the blood. It is getting carnitine into muscle, where fat is burned.

The Nottingham group that ran the 2006 study summed up the earlier work bluntly: attempts to raise muscle carnitine in healthy people by diet or by intravenous carnitine had failed.^[10] Their infusion worked only when they also clamped insulin at high levels for hours, a hospital procedure. A 2020 Dutch study infused carnitine without that clamp and found no change in muscle carnitine at all.^[9] A shot raises blood carnitine for a while, and the kidneys clear much of it within a day.^[1]

The one weight result from injected carnitine is the 2014 Chinese pilot. Fifteen people on a five-day modified fast who got intravenous carnitine lost 1.4 kg more over a week than fifteen who got saline.^[8] That was a hospital drip during near-starvation, single-blind, lasting one week, with weight as only one of many measures. It does not describe a weekly shot at a clinic. No published randomized trial has tested intramuscular carnitine shots for weight loss.

TMAO: what the studies show and what they do not

The main worry about carnitine supplements is TMAO (trimethylamine N-oxide), a compound the body makes from carnitine with the help of gut bacteria. The research behind the concern:

• Mice and a large patient cohort. In a 2013 Nature Medicine study, carnitine fed to mice raised TMAO and sped up hardening of the arteries, but not when their gut bacteria were suppressed. In 2,595 people undergoing heart evaluation, higher blood carnitine predicted heart disease and major cardiac events only among those who also had high TMAO.^[12]
• Diet shapes the effect. Given a tagged dose of carnitine, meat eaters made more than 20 times as much labeled TMAO as vegans and vegetarians, and taking carnitine for two months or more strengthened the gut pathway that produces it.^[13]
• Supplement doses. In a 2025 study of healthy volunteers taking 0.5 or 1.5 g, about 90% of the carnitine was turned into TMAO, with blood levels reaching 50 µM, a range previous research has linked to worse health outcomes.^[14]
• The label agrees on the chemistry. Carnitor’s label lists TMAO as a major metabolite of oral carnitine and warns that high oral doses in people with severe kidney disease or on dialysis may let TMA and TMAO build up.^[1]

What this does not show: no trial has found that carnitine supplements cause heart attacks or strokes in people. The human evidence links TMAO to heart disease by association, and the causal experiments were in mice. The 2019 paper also discloses that several authors hold patents on cardiovascular diagnostics and some are employees of a consumer-goods company.^[13]

Route matters here, and it cuts in favor of the injection on this one point. TMAO starts in the gut, so injected carnitine may largely skip that step. In one mouse study, carnitine given under the skin raised blood carnitine without raising TMAO or worsening artery plaque, while the same carnitine given by mouth did both.^[15] That is mice. No study has measured TMAO in people after carnitine shots.

L-carnitine added to a compounded GLP-1 vial

Some compounded semaglutide and tirzepatide is sold with L-carnitine mixed in, usually described as support for fat burning or energy. FDA has said it is aware of compounders adding levocarnitine, B12, B6 and NAD to semaglutide products, and that the safety and effectiveness of the combination have not been established.^[2] There is no approved GLP-1 product that contains carnitine.

There is also no study of the combination. No published trial, of any size, has given carnitine with semaglutide, tirzepatide or liraglutide and measured weight. The only published paper tying carnitine to semaglutide runs the other way: a single case report of a man with a rare inherited fat-metabolism disorder whose carnitine fell after he switched to semaglutide tablets, which the authors traced to an absorption-enhancer in the tablet, not to semaglutide.^[17] It says nothing about injections or about adding carnitine.

What the added carnitine certainly does is put a second ingredient and a second strength on the label. Know which number is the GLP-1 before you draw up a dose; our guide to what is in a compounded GLP-1 vial walks through reading one, and the vial label reader does the arithmetic. For how FDA treats additives under its compounding rules, see GLP-1s with glycine, B6 or niacinamide, and for the most common pairing, semaglutide compounded with B12.

Side effects and safety

Carnitine is not highly toxic, but injecting it is not risk-free. The Carnitor label, written for intravenous use under medical supervision, lists these:^[1]

• Serious allergic reactions, including anaphylaxis, throat swelling and bronchospasm, some within minutes of an intravenous dose, mostly reported in dialysis patients.
• Seizures, reported after oral or intravenous carnitine in people with and without a seizure history.
• Warfarin. Reports of a rising INR; the label advises checking INR after starting or changing carnitine.
• Stomach upset and body odor. Nausea, vomiting and gastritis, plus body odor.

For oral use, a 2006 risk assessment put the observed safe level at 2,000 mg a day, and said the data above that were not enough for a confident conclusion about long-term safety.^[16] Its authors worked for a supplement trade association. There is no comparable safety assessment for repeated intramuscular shots in healthy adults. A shot from a clinic also carries the ordinary risks of any compounded injectable: sterility, the right strength, and the right ingredient. Our guide to 503A vs 503B pharmacies explains who makes these products and under what rules.

Before you pay for a carnitine shot

• Ask what the claim is based on. If the answer is oral supplement studies, the honest expected effect is about a kilogram over months, not a shot’s worth of fat burned.
• Ask if you are deficient. A blood carnitine level is how the approved drug is started. If nobody measured yours, nobody knows you need it.
• Tell the prescriber if you take warfarin or have a seizure disorder or kidney disease. All three appear on the levocarnitine label.
• For a GLP-1 vial with carnitine, ask whether the same pharmacy sells the GLP-1 alone, and compare. The carnitine adds an ingredient with no tested benefit in the combination.
• Check the seller. Our pharmacy verification guide covers licensing and what to look for on a label. Similar injectable add-ons, such as NAD, are reviewed in what the evidence shows on NAD injections.